# Feature 006 Closure Record

**Feature**: Safira Independent Safety Estimator Calibration
**Feature directory**: `specs/006-independent-safety-estimator-calibration/`
**Branch**: `feature-06/Independent-calibration`
**Closed**: 2026-10-21
**Verified implementation commit (HEAD before closure)**: `6847bd69e753d7f0fe370b783706dd84b08326db`

## Closure evidence

- Implementation tasks: **48/48 complete**; see [tasks.md](tasks.md).
- Final independent adversarial verification: **Audits A–K, 11 PASS; no confirmed implementation defects**.
- Feature 006 tests: **92 passed**.
- Features 001–005 regression tests: **659 passed**.
- Full pytest suite: **751 passed, 0 failed, 0 skipped** (as reported by the completed verification run).
- `git diff --check`: passed in the completed verification run.
- Approved methodology decisions **A–G** are preserved in [decision-record.md](decision-record.md).
- No Feature 001–005 source or public contracts changed in the verified implementation branch.

The successful result is an immutable `CALIBRATOR_FITTED_UNEVALUATED` artifact. The calibration fitting partition is spent. Feature 005 validation remains spent for estimator selection, and Feature 003 protected final-test evidence remains inaccessible to Feature 006.

## Scope and limitations

1. Fitted mappings have **not** been independently evaluated.
2. Successful synthetic software tests do not establish population calibration quality.
3. No production trust ledger or artifact-origin custodian is configured.
4. In-memory artifacts and canonical digests do not, by themselves, establish durable storage or authorized origin.
5. No public per-patient calibrated-score application API exists.
6. No safety-decision policy or clinical thresholds have been approved.
7. Clinical validity, deployment readiness and patient-safety effectiveness have not been demonstrated.
8. Independent future evaluation and any policy-selection process require separately authorized evidence.
9. Feature 005 validation and Feature 006 calibration fitting partitions remain spent for their approved purposes.
10. Feature 003 protected final-test evidence remains inaccessible under Feature 006.

Feature 006 is closed within its approved research-software scope. This closure does not claim scientific or clinical validity.
